Omeprazole and Viokace drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Omeprazole (omeprazole) and Viokace (pancrelipase (amylase;lipase;protease)). Common drug interactions include cystic fibrosis among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Omeprazole and Viokace. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Omeprazole?

Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 410,631 Omeprazole users. Check the latest studies of Omeprazole.

What is Viokace?

Viokace has active ingredients of pancrelipase (amylase;lipase;protease). eHealthMe is studying from 208 Viokace users. Check the latest studies of Viokace.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

24 people who take Omeprazole and Viokace together, and have interactions are studied.

Omeprazole and Viokace drug interactions.

What are the common drug interactions of Omeprazole and Viokace, by gender? *:

female:

Cystic fibrosis (disease of the secretary glands)
Fungal infection
Urinary tract infection
Abdominal discomfort
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
Tooth disorder (tooth disease)
Adenoidal hypertrophy (enlarged adenoids)
Alanine aminotransferase increased
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Aspartate aminotransferase increased

male:

Abdominal pain
Blood urea increased
Lung disorder (lung disease)
Pancreatitis (inflammation of pancreas)
Diarrhoea
Headache (pain in head)
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
International normalised ratio increased
Otitis media (inflammation of the middle ear)
Pneumonia

What are the common drug interactions of Omeprazole and Viokace, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Sinus polyp (abnormal tissue growths that grow inside the nasal passages and sinuses)
Tonsillar hypertrophy (enlargement of the tonsils)
Cystic fibrosis (disease of the secretary glands)
Adenoidal hypertrophy (enlarged adenoids)
Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
Nasal polyps (masses that develop in the lining of the nose)

10-19:

Abdominal pain
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Blood urea increased
Diarrhoea
Headache (pain in head)
International normalised ratio increased
Otitis media (inflammation of the middle ear)
Pneumonia
Weight increased
Hepatic enzyme decreased

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Alanine aminotransferase increased
Aspartate aminotransferase increased
Conjunctival irritation
Hepatotoxicity (chemical-driven liver damage)
Lacrimal disorder (disease of lacrimal duct)
Lacrimation increased

60+:

n/a

What are the existing conditions these people have? *

Cystic Fibrosis (disease of the secretary glands): 18 people, 75.00%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 4 people, 16.67%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 16.67%
Constipation: 2 people, 8.33%
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Omeprazole and Viokace?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously